Latest trends in United Kingdom - What people search
astrazeneca
Jefferies sees 'key nuance' in comparing NewAmsterdam to AstraZeneca data - TipRanks.com - TipRanks
Jefferies sees 'key nuance' in comparing NewAmsterdam to AstraZeneca data - TipRanks.com TipRanks
Published on 30 May 2024 | 6:16 pm
AstraZeneca and Daiichi Sankyo announce positive results from phase 3 lung cancer study - PMLiVE
AstraZeneca and Daiichi Sankyo announce positive results from phase 3 lung cancer study PMLiVE
Published on 30 May 2024 | 11:24 am
AstraZeneca started at buy at Goldman, which rates GSK a neutral - MarketWatch
AstraZeneca started at buy at Goldman, which rates GSK a neutral MarketWatch
Published on 30 May 2024 | 10:34 am
Astrazeneca Pharma India Q4 Results Live : profit rise by 128.61% YOY | Company Business News - Mint
Astrazeneca Pharma India Q4 Results Live : profit rise by 128.61% YOY | Company Business News Mint
Published on 29 May 2024 | 8:37 pm
Fusion Pharmaceuticals Shareholders Approve Acquisition by AstraZeneca - PR Newswire
Fusion Pharmaceuticals Shareholders Approve Acquisition by AstraZeneca PR Newswire
Published on 29 May 2024 | 8:05 pm
AstraZeneca Just Massively One-Upped Pfizer. Here's What It Means for the Stock - Yahoo Finance
AstraZeneca Just Massively One-Upped Pfizer. Here's What It Means for the Stock Yahoo Finance
Published on 29 May 2024 | 2:07 pm
AstraZeneca Just Massively One-Upped Pfizer. Here's What It Means for the Stock - The Motley Fool
AstraZeneca Just Massively One-Upped Pfizer. Here's What It Means for the Stock The Motley Fool
Published on 29 May 2024 | 2:07 pm
Amgen Wins FDA Approval for First Biosimilar to AstraZeneca’s Soliris - BioSpace
Amgen Wins FDA Approval for First Biosimilar to AstraZeneca’s Soliris BioSpace
Published on 29 May 2024 | 1:15 pm
How Realistic is AstraZeneca’s $80B Revenue Target by 2030? - BioSpace
How Realistic is AstraZeneca’s $80B Revenue Target by 2030? BioSpace
Published on 29 May 2024 | 12:48 pm
AstraZeneca’s Ambitious Target, Pharma Layoffs Continue and ASCO - BioSpace
AstraZeneca’s Ambitious Target, Pharma Layoffs Continue and ASCO BioSpace
Published on 29 May 2024 | 12:15 pm
AstraZeneca Plans to Rake in $80 Billion by 2030. Should You Buy the Stock? - Yahoo Finance
AstraZeneca Plans to Rake in $80 Billion by 2030. Should You Buy the Stock? Yahoo Finance
Published on 29 May 2024 | 12:06 pm
AstraZeneca Plans to Rake in $80 Billion by 2030. Should You Buy the Stock? - The Motley Fool
AstraZeneca Plans to Rake in $80 Billion by 2030. Should You Buy the Stock? The Motley Fool
Published on 29 May 2024 | 12:06 pm
AstraZeneca throws its hat into the oral PCSK9 ring - pharmaphorum
AstraZeneca throws its hat into the oral PCSK9 ring pharmaphorum
Published on 29 May 2024 | 8:17 am
European Medicines Agency pulls authorization for AstraZeneca's COVID shot, at company's request - Yahoo Singapore News
European Medicines Agency pulls authorization for AstraZeneca's COVID shot, at company's request Yahoo Singapore News
Published on 29 May 2024 | 6:42 am
US FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment - Reuters
US FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment Reuters
Published on 28 May 2024 | 11:27 pm
New lung cancer drug boosts AstraZeneca as trials show improved survival rates - This is Money
New lung cancer drug boosts AstraZeneca as trials show improved survival rates This is Money
Published on 28 May 2024 | 9:00 pm
Why Is AstraZeneca Stock Trading Lower On Tuesday? - Yahoo Finance
Why Is AstraZeneca Stock Trading Lower On Tuesday? Yahoo Finance
Published on 28 May 2024 | 8:32 pm
AstraZeneca, Daiichi Sankyo ADC Misses Endpoint in Phase III NSCLC Study - BioSpace
AstraZeneca, Daiichi Sankyo ADC Misses Endpoint in Phase III NSCLC Study BioSpace
Published on 28 May 2024 | 12:58 pm
AstraZeneca-Daiichi's Enhertu follow-up Dato-DXd unable to prove overall survival benefit in phase 3 - Fierce Biotech
AstraZeneca-Daiichi's Enhertu follow-up Dato-DXd unable to prove overall survival benefit in phase 3 Fierce Biotech
Published on 28 May 2024 | 11:06 am
AstraZeneca experimental lung cancer drug shows promising results - ShareCast
AstraZeneca experimental lung cancer drug shows promising results ShareCast
Published on 28 May 2024 | 6:41 am
Here's Why Astrazeneca (AZN) is a Strong Growth Stock - Yahoo Finance
Here's Why Astrazeneca (AZN) is a Strong Growth Stock Yahoo Finance
Published on 27 May 2024 | 1:45 pm
AstraZeneca and Daiichi Sankyo's ADC improves survival in NSCLC trial - Clinical Trials Arena
AstraZeneca and Daiichi Sankyo's ADC improves survival in NSCLC trial Clinical Trials Arena
Published on 27 May 2024 | 11:11 am
Fierce Pharma Asia—AstraZeneca eyes China's innovation, plots Singapore ADC plant; FDA rejects Hengrui's PD-1 drug - FiercePharma
Fierce Pharma Asia—AstraZeneca eyes China's innovation, plots Singapore ADC plant; FDA rejects Hengrui's PD-1 drug FiercePharma
Published on 24 May 2024 | 12:31 pm
AstraZeneca and Nona sign agreement for monoclonal antibody - Pharmaceutical Technology
AstraZeneca and Nona sign agreement for monoclonal antibody Pharmaceutical Technology
Published on 23 May 2024 | 10:12 am
AstraZeneca pays $19M to Harbour BioMed's Nona for preclinical cancer antibodies - Fierce Biotech
AstraZeneca pays $19M to Harbour BioMed's Nona for preclinical cancer antibodies Fierce Biotech
Published on 23 May 2024 | 9:58 am
AstraZeneca makes another obesity play funnelling $80m into SixPeaks Bio - Pharmaceutical Technology
AstraZeneca makes another obesity play funnelling $80m into SixPeaks Bio Pharmaceutical Technology
Published on 22 May 2024 | 3:16 pm
AstraZeneca to climb weight loss mountain with $80M for SixPeaks - Fierce Biotech
AstraZeneca to climb weight loss mountain with $80M for SixPeaks Fierce Biotech
Published on 22 May 2024 | 7:00 am
AstraZeneca sets out ambitious growth plan - Investors Chronicle
AstraZeneca sets out ambitious growth plan Investors Chronicle
Published on 21 May 2024 | 2:29 pm
AstraZeneca aims to nearly double revenues to $80bn by 2030 - The Guardian
AstraZeneca aims to nearly double revenues to $80bn by 2030 The Guardian
Published on 21 May 2024 | 9:49 am
AstraZeneca sets bold revenue target as CEO aims to double sales to $80 billion by 2030 - Fortune
AstraZeneca sets bold revenue target as CEO aims to double sales to $80 billion by 2030 Fortune
Published on 21 May 2024 | 8:32 am
Will AstraZeneca be the UK’s first £200bn company? - The Guardian
Will AstraZeneca be the UK’s first £200bn company? The Guardian
Published on 21 May 2024 | 7:00 am
AZ plans to launch 20 new drugs and achieve $80B revenue by 2030 - FiercePharma
AZ plans to launch 20 new drugs and achieve $80B revenue by 2030 FiercePharma
Published on 21 May 2024 | 7:00 am
AstraZeneca to build Chinese supply chain as US-Sino tensions increase - Financial Times
AstraZeneca to build Chinese supply chain as US-Sino tensions increase Financial Times
Published on 21 May 2024 | 7:00 am
AstraZeneca aims for $80 bln in total revenue by 2030 - Reuters
AstraZeneca aims for $80 bln in total revenue by 2030 Reuters
Published on 21 May 2024 | 7:00 am
AstraZeneca targets $80bn in yearly revenues by 2030 - This is Money
AstraZeneca targets $80bn in yearly revenues by 2030 This is Money
Published on 21 May 2024 | 7:00 am
AstraZeneca targets $80 billion in total revenue by 2030 in 'post-Covid era' - CNBC
AstraZeneca targets $80 billion in total revenue by 2030 in 'post-Covid era' CNBC
Published on 21 May 2024 | 7:00 am
Pfizer wins cancer drug patent case against AstraZeneca - Pharmaceutical Technology
Pfizer wins cancer drug patent case against AstraZeneca Pharmaceutical Technology
Published on 20 May 2024 | 7:00 am
AZ told to pay Pfizer $107.5M for patent infringement - FiercePharma
AZ told to pay Pfizer $107.5M for patent infringement FiercePharma
Published on 20 May 2024 | 7:00 am
AstraZeneca to build $1.5bn manufacturing site in Singapore - Financial Times
AstraZeneca to build $1.5bn manufacturing site in Singapore Financial Times
Published on 20 May 2024 | 7:00 am
AstraZeneca to build $1.5-bln cancer drug plant in Singapore - Reuters
AstraZeneca to build $1.5-bln cancer drug plant in Singapore Reuters
Published on 20 May 2024 | 7:00 am
'I was paralysed after getting the jab... but the payout won't cover the cost of my disability': AstraZeneca v - Daily Mail
Published on 19 May 2024 | 7:00 am
Doctor explains science behind AstraZeneca's Covid jab blood clot admission - The Independent
Doctor explains science behind AstraZeneca's Covid jab blood clot admission The Independent
Published on 9 May 2024 | 7:00 am
AstraZeneca starts worldwide withdrawal of COVID vaccine - Sky News
AstraZeneca starts worldwide withdrawal of COVID vaccine Sky News
Published on 8 May 2024 | 7:00 am
AstraZeneca withdraws Covid-19 vaccine worldwide, citing surplus of newer vaccines - The Guardian
AstraZeneca withdraws Covid-19 vaccine worldwide, citing surplus of newer vaccines The Guardian
Published on 8 May 2024 | 7:00 am
FactCheck: why is the AstraZeneca Covid vaccine being withdrawn worldwide? - Channel 4 News
FactCheck: why is the AstraZeneca Covid vaccine being withdrawn worldwide? Channel 4 News
Published on 8 May 2024 | 7:00 am
AstraZeneca to withdraw Covid vaccine - BBC.com
AstraZeneca to withdraw Covid vaccine BBC.com
Published on 8 May 2024 | 7:00 am
AstraZeneca withdraws Covid vaccine after admitting it can cause rare blood clots - The Independent
AstraZeneca withdraws Covid vaccine after admitting it can cause rare blood clots The Independent
Published on 8 May 2024 | 7:00 am
AstraZeneca withdraws Covid-19 vaccine - Financial Times
AstraZeneca withdraws Covid-19 vaccine Financial Times
Published on 8 May 2024 | 7:00 am
AstraZeneca starts worldwide withdrawal of COVID vaccine | News UK Video News - Sky News
AstraZeneca starts worldwide withdrawal of COVID vaccine | News UK Video News Sky News
Published on 8 May 2024 | 7:00 am
AstraZeneca withdrawing Covid vaccine worldwide - The Telegraph
AstraZeneca withdrawing Covid vaccine worldwide The Telegraph
Published on 7 May 2024 | 7:00 am
Upskilling employees in the age of AI Supporting - AstraZeneca
Upskilling employees in the age of AI Supporting AstraZeneca
Published on 3 May 2024 | 7:00 am
Bereaved families abandon attempts to sue AstraZeneca over Covid vaccine - The Telegraph
Bereaved families abandon attempts to sue AstraZeneca over Covid vaccine The Telegraph
Published on 2 May 2024 | 7:00 am
AstraZeneca admits Covid-19 vaccine may cause blood clots in “very rare” cases - Pharmaceutical Technology
AstraZeneca admits Covid-19 vaccine may cause blood clots in “very rare” cases Pharmaceutical Technology
Published on 1 May 2024 | 7:00 am
In a first, AstraZeneca admits its Covid vaccine can cause rare blood clots - The Independent
In a first, AstraZeneca admits its Covid vaccine can cause rare blood clots The Independent
Published on 30 April 2024 | 7:00 am
AstraZeneca admits rare blood clot risk from covid jabs as it faces class action lawsuit in UK | Company Business News - Mint
Published on 30 April 2024 | 7:00 am
The two sides of AstraZeneca's vaccine 'miracle' - The Telegraph
The two sides of AstraZeneca's vaccine 'miracle' The Telegraph
Published on 30 April 2024 | 7:00 am
Dad who suffered brain injury days after getting COVID vaccine sues AstraZeneca - Sky News
Dad who suffered brain injury days after getting COVID vaccine sues AstraZeneca Sky News
Published on 29 April 2024 | 7:00 am
AstraZeneca admits its Covid vaccine can cause rare side effect in court documents for first time - The Telegraph
AstraZeneca admits its Covid vaccine can cause rare side effect in court documents for first time The Telegraph
Published on 28 April 2024 | 7:00 am
Product sustainability - AstraZeneca
Product sustainability AstraZeneca
Published on 25 April 2024 | 7:00 am
Social Media Community Guidelines - AstraZeneca
Social Media Community Guidelines AstraZeneca
Published on 25 April 2024 | 7:00 am
AstraZeneca Q1 2023 results - Investor Webcast - AstraZeneca
AstraZeneca Q1 2023 results - Investor Webcast AstraZeneca
Published on 25 April 2024 | 7:00 am
Home / Partnering / Our areas of partnering interest - AstraZeneca
Home / Partnering / Our areas of partnering interest AstraZeneca
Published on 25 April 2024 | 7:00 am
Environmental protection - Our Company - AstraZeneca
Environmental protection - Our Company AstraZeneca
Published on 25 April 2024 | 7:00 am
Our approach to Water stewardship - Sustainability - AstraZeneca
Our approach to Water stewardship - Sustainability AstraZeneca
Published on 25 April 2024 | 7:00 am
Externally Sponsored Scientific Research Training Centre - AstraZeneca
Externally Sponsored Scientific Research Training Centre AstraZeneca
Published on 25 April 2024 | 7:00 am
Transformative science - AstraZeneca
Transformative science AstraZeneca
Published on 25 April 2024 | 7:00 am
Europe falling behind US and China in pharma innovation, warns AstraZeneca chief - Financial Times
Europe falling behind US and China in pharma innovation, warns AstraZeneca chief Financial Times
Published on 25 April 2024 | 7:00 am
Access to healthcare - Our Company - AstraZeneca
Access to healthcare - Our Company AstraZeneca
Published on 25 April 2024 | 7:00 am
Early Talent - careers.astrazeneca.com
Early Talent careers.astrazeneca.com
Published on 25 April 2024 | 7:00 am
STEM at AstraZeneca - AstraZeneca
STEM at AstraZeneca AstraZeneca
Published on 25 April 2024 | 7:00 am
Supporting our communities - AstraZeneca
Supporting our communities AstraZeneca
Published on 25 April 2024 | 7:00 am
The AstraZeneca iLab - AstraZeneca
The AstraZeneca iLab AstraZeneca
Published on 25 April 2024 | 7:00 am
Partnerships, alliances and recognition - AstraZeneca
Partnerships, alliances and recognition AstraZeneca
Published on 25 April 2024 | 7:00 am
Clinical innovation - What science can do stories - AstraZeneca
Clinical innovation - What science can do stories AstraZeneca
Published on 25 April 2024 | 7:00 am
Proxy advisers inflict 'serious harm' to UK, says AstraZeneca chair - Financial Times
Proxy advisers inflict 'serious harm' to UK, says AstraZeneca chair Financial Times
Published on 14 April 2024 | 7:00 am
The danger in saying yes to Pascal Soriot’s pay rise at AstraZeneca - The Guardian
The danger in saying yes to Pascal Soriot’s pay rise at AstraZeneca The Guardian
Published on 11 April 2024 | 7:00 am
'Barely-Disguised' Dividend Hike Boosts AstraZeneca... - Morningstar
'Barely-Disguised' Dividend Hike Boosts AstraZeneca... Morningstar
Published on 11 April 2024 | 7:00 am
AstraZeneca shareholders approve CEO Soriot's £18.7mn pay despite revolt - Financial Times
AstraZeneca shareholders approve CEO Soriot's £18.7mn pay despite revolt Financial Times
Published on 11 April 2024 | 7:00 am
AstraZeneca's Pascal Soriot 'massively underpaid' at £16.9mn, says top shareholder - Financial Times
AstraZeneca's Pascal Soriot 'massively underpaid' at £16.9mn, says top shareholder Financial Times
Published on 9 April 2024 | 7:00 am
A decade after Pfizer, AstraZeneca needs to find its growth again - Financial Times
A decade after Pfizer, AstraZeneca needs to find its growth again Financial Times
Published on 31 March 2024 | 7:00 am
AstraZeneca shareholders urged to oppose pay plan for CEO Soriot - Financial Times
AstraZeneca shareholders urged to oppose pay plan for CEO Soriot Financial Times
Published on 30 March 2024 | 7:00 am
A timeline of our company history - AstraZeneca
A timeline of our company history AstraZeneca
Published on 28 March 2024 | 11:25 am
AstraZeneca to buy Canadian cancer specialist Fusion for $2.4bn - The Guardian
AstraZeneca to buy Canadian cancer specialist Fusion for $2.4bn The Guardian
Published on 19 March 2024 | 7:00 am
AstraZeneca strikes $2.4bn deal for radiotherapy biotech Fusion - Financial Times
AstraZeneca strikes $2.4bn deal for radiotherapy biotech Fusion Financial Times
Published on 19 March 2024 | 7:00 am
Q1 2024 results - Investor Webcast & event information - AstraZeneca
Q1 2024 results - Investor Webcast & event information AstraZeneca
Published on 11 March 2024 | 11:59 pm
The importance of championing women in a digital world - AstraZeneca
The importance of championing women in a digital world AstraZeneca
Published on 8 March 2024 | 8:00 am
AstraZeneca plans £650 million investment in UK - GOV.UK
AstraZeneca plans £650 million investment in UK GOV.UK
Published on 6 March 2024 | 8:00 am
New drug launches weigh on AstraZeneca profits - Financial Times
New drug launches weigh on AstraZeneca profits Financial Times
Published on 7 February 2024 | 8:00 am
AstraZeneca set to make one of its first acquisitions in China - Financial Times
AstraZeneca set to make one of its first acquisitions in China Financial Times
Published on 26 December 2023 | 8:00 am
Strategic partner: AstraZeneca - University of Cambridge news
Strategic partner: AstraZeneca University of Cambridge news
Published on 18 December 2023 | 11:02 am
AstraZeneca strikes $1bn deal to acquire its first vaccine company - Financial Times
AstraZeneca strikes $1bn deal to acquire its first vaccine company Financial Times
Published on 12 December 2023 | 8:00 am
Using AI to guide AZ Forest Kenya reforestation initiative - AstraZeneca
Using AI to guide AZ Forest Kenya reforestation initiative AstraZeneca
Published on 1 December 2023 | 8:00 am
Cambridge partners with AstraZeneca and Medical Research Council on new world-class functional genomics laboratory - University of Cambridge news
Cambridge partners with AstraZeneca and Medical Research Council on new world-class functional genomics laboratory University of Cambridge news
Published on 27 November 2023 | 8:00 am
AstraZeneca launches healthtech business Evinova - AstraZeneca
AstraZeneca launches healthtech business Evinova AstraZeneca
Published on 20 November 2023 | 8:00 am
Coronavirus (COVID-19) information & research hub - AstraZeneca
Coronavirus (COVID-19) information & research hub AstraZeneca
Published on 16 November 2023 | 7:06 pm
AstraZeneca signs deal for oral obesity drug and lifts profit outlook - Financial Times
AstraZeneca signs deal for oral obesity drug and lifts profit outlook Financial Times
Published on 9 November 2023 | 8:00 am
Decarbonising respiratory care and improving patient outcomes - AstraZeneca
Decarbonising respiratory care and improving patient outcomes AstraZeneca
Published on 2 November 2023 | 7:00 am